Timothy Perren: Consultant Medical Oncologist and Cancer Specialist, Leeds
Consultant Medical Oncologist and Cancer Specialist, Leeds: Timothy Perren
Consultant Medical Oncologist who specialises in providing high quality cancer diagnosis, medical treatment, and follow-up for women (and men) with breast cancer, and women with ovarian, uterine or cervical cancer.
Dr Perren is a senior consultant oncologist at Spire Leeds Hospital and St James’s Institute of Oncology in Leeds. Dr Perren specialises in the medical treatment of cancers using chemotherapy, hormonal therapy, supportive therapies such as bisphosphonates, and the new targeted molecular therapies such as trastuzumab (Herceptin), lapatinib (Tyverb), and bevacizumab (Avastin).
Modern treatment for cancer requires the careful integration of diagnostic procedures, surgical treatment, medical therapies, and radiotherapy. This is brought about through a multidisciplinary team approach where pathologists, radiologists, oncologists, surgeons, and specialist nurses meet on a regular basis to consider the diagnosis and optimal treatment for individual patients.
Dr Perren is a member of the multidisciplinary team for breast cancer, and is lead for the multidisciplinary team for gynaecological cancers at the Leeds Cancer Centre which is based at the St James’s Institute of Oncology within the Leeds Teaching Hospitals NHS Trust. Dr Perren works with the same team of surgeons, radiologists, and pathologists in the private sector as he does in the NHS.
Modern cancer treatment is increasingly becoming tailored to the individual patient and their particular cancer through careful analysis of the nature and extent of the disease together with information regarding certain biological and molecular features exhibited by the cancer. So one patient with, say breast cancer, will not necessarily need to have the same treatment as another patient who apparently has the same disease.
Oncologists are involved at all stages in the pathway of care, and today, where appropriate, chemotherapy or hormonal therapy maybe used as the initial form of treatment.
Dr Perren qualified from Charing Cross Hospital Medical School in London in 1978. He subsequently trained in general medicine in London and in Stoke on Trent. His oncology training was in Birmingham and at the Royal Marsden Hospital. He was appointed consultant medical oncologist at St James's Hospital in Leeds in January 1990. He is a fellow of the Royal College of Physicians of London, a member of the Association of Cancer Physicians Executive Committee, the American Society of Clinical Oncology and the European Society of Medical Oncology. He is a past Chair and member of the Joint Speciality Committee for Medical Oncology at the Royal College of Physicians of London as well as of the Joint Collegiate Council for Oncology. He proposed the NCEPOD investigation into deaths within 30 days of chemotherapy administration, which has led to wholesale changes in the planning and administration of chemotherapy services in the UK.
St James's Institute of Oncology
Specialist cancer expertise and treatments offered
Dr Perren has many years of expertise in chemotherapy and hormonal therapy for breast cancer (in men as well as in women) and the whole range of gynaecological cancers. The gynaecological cancers include, ovarian cancer; primary peritoneal cancer – a condition which is often confused with ovarian cancer; ovarian germ cell tumours (often known as ovarian teratomas or yolk sac tumours); fallopian tube cancer; endometrial cancer (cancer of the lining of the womb); cervix or cervical cancer, vaginal cancer; vulval cancer. There are a number of rarer gynaecological malignancies such as carcinosarcomas (sometimes known as mixed mullerian tumour), or various other forms of sarcoma which can affect either the ovary or the endometrium.
Dr Perren has expertise in treating patients with both newly diagnosed early cancer, and cancer which has recurred after previous treatments. On occasions patients are diagnosed with advanced cancer and it is not clear which organ the cancer has developed from; this is known as cancer of unknown primary site. Dr Perren, with his colleagues in diagnostic radiology and pathology, are very familiar with the appropriate investigation of this form of cancer so that optimal treatments may be offered.
Clinical research interests in cancer treatment
Through his NHS practice, Dr Perren is involved in many research trials investigating the integration of new treatments into cancer care. It is of course only through the recruitment of patients into well designed clinical trials and studies that progress can be made into the treatment of cancer. Therefore clinical trials are central to modern cancer care.
Many of the current trials are investigating targeted molecular therapies at all stages of cancer care. Dr Perren is the International Chief Investigator for the MRC ICON7 Trial which was set up to investigate the role of bevacizumab (Avastin) as part of the initial chemotherapy treatment for ovarian cancer. That trial is now closed to recruitment and initial results are expected during the course of 2010.
Within the newly established Nova Healthcare Private Oncology Unit at the St James’s Institute of Oncology, there are plans to establish a service where patients seeking private healthcare for their cancer can also access the range of clinical trials and studies available to patients being treated within the NHS.
Dr Perren is author or co-author of more than 100 research papers, book chapters and abstracts.
Where can I get cancer treatment?
Dr Perren is Consultant Medical Oncologist at the St James’s Institute of Oncology in Leeds, West Yorkshire. This is based with the newly developed Bexley Wing at St James’s University Hospital, part of the Leeds Teaching Hospitals NHS Trust.
Spire Leeds Hospital
This is a well established private hospital located in beautiful landscaped grounds in Roundhay in North Leeds. The hospital has a resident medical officer and offers inpatient, outpatient, and day case facilities. There is a team of specialist chemotherapy nurses and a purpose-built dedicated day case chemotherapy unit will open in September 2009. Modern comprehensive imaging is also available on site. Currently most of Dr Perren’s consultations and treatments are carried out here.
Nova Healthcare, St James’s Institute of Oncology
This is a newly established unit based within the newly opened state-of-the-art Cancer Centre in the Bexley Wing at St James’s. The unit currently offers consultation suites, the private radiotherapy service for West Yorkshire, and a newly developed Gamma Knife Centre. Services for chemotherapy and clinical trials will be developed during 2009/10. Consultations can be arranged as required within the Nova Oncology Unit.
Accreditation and admitting rights at private hospitals
Mr. Timothy Perren is an accredited consultant for the UK's leading private healthcare providers and private hospitals including Spire Healthcare.
Intuition Communication Ltd bears no responsibility for information published on this website, which concerns or relates to advertisers and their products and services. Read Disclaimer in full.